Dow Institute of Biological Biochemical & Pharmaceutical Sciences-IBBPS

  • Home
  • Pakistan
  • Karachi
  • Dow Institute of Biological Biochemical & Pharmaceutical Sciences-IBBPS

Dow Institute of Biological Biochemical & Pharmaceutical Sciences-IBBPS Contract Research Organization (CRO) | Clinical Trials Study Centre | Bioequivalence Study Centre

Excited to welcome our newest joiner ๐ƒ๐ซ. ๐‘๐ฎ๐›๐š๐› ๐…๐š๐ญ๐ข๐ฆ๐š as ๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐Ž๐Ÿ๐Ÿ๐ข๐œ๐ž๐ซ to the IBPPS family!Your unique talents and fre...
24/01/2026

Excited to welcome our newest joiner ๐ƒ๐ซ. ๐‘๐ฎ๐›๐š๐› ๐…๐š๐ญ๐ข๐ฆ๐š as ๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐Ž๐Ÿ๐Ÿ๐ข๐œ๐ž๐ซ to the IBPPS family!

Your unique talents and fresh perspectives will surely elevate our team to new heights.

Here's to collaboration, growth, and success together! ๐Ÿ’ผโœจ

๐…๐ซ๐จ๐ฆ ๐Œ๐จ๐ฅ๐ž๐œ๐ฎ๐ฅ๐ž ๐ญ๐จ ๐Œ๐š๐ซ๐ค๐ž๐ญ โ€” ๐๐ข๐จ๐ž๐ช๐ฎ๐ข๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž ๐ญ๐ก๐š๐ญ ๐›๐ซ๐ข๐๐ ๐ž๐ฌ ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ฐ๐ข๐ญ๐ก ๐ฉ๐š๐ญ๐ข๐ž๐ง๐ญ ๐š๐œ๐œ๐ž๐ฌ๐ฌ.At the Dow Institute of Biological,...
20/01/2026

๐…๐ซ๐จ๐ฆ ๐Œ๐จ๐ฅ๐ž๐œ๐ฎ๐ฅ๐ž ๐ญ๐จ ๐Œ๐š๐ซ๐ค๐ž๐ญ โ€” ๐๐ข๐จ๐ž๐ช๐ฎ๐ข๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž ๐ญ๐ก๐š๐ญ ๐›๐ซ๐ข๐๐ ๐ž๐ฌ ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ฐ๐ข๐ญ๐ก ๐ฉ๐š๐ญ๐ข๐ž๐ง๐ญ ๐š๐œ๐œ๐ž๐ฌ๐ฌ.

At the Dow Institute of Biological, Biochemical & Pharmaceutical Sciences (IBBPS-DUHS), our Certified Bioequivalence Center delivers end-to-end clinical and bioanalytical services, ensuring your generic products meet regulatory and scientific standards.

โœ” Trained Clinical Research Staff
โœ” Validated Bioanalysis
โœ” Regulatory-Ready Statistical Reporting

Partner with us to accelerate your productโ€™s journey to approval.

Visit Now: https://lnkd.in/eKT2BARs

We proudly highlight another insightful session of the ๐๐ซ๐จ๐Ÿ๐ž๐ฌ๐ฌ๐ข๐จ๐ง๐š๐ฅ ๐ƒ๐ข๐ฉ๐ฅ๐จ๐ฆ๐š ๐ข๐ง ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐’๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ (๐๐š๐ญ๐œ๐ก...
16/01/2026

We proudly highlight another insightful session of the ๐๐ซ๐จ๐Ÿ๐ž๐ฌ๐ฌ๐ข๐จ๐ง๐š๐ฅ ๐ƒ๐ข๐ฉ๐ฅ๐จ๐ฆ๐š ๐ข๐ง ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐’๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ (๐๐š๐ญ๐œ๐ก ๐Ÿ), conducted by MUJAHID HUSSAIN, focusing on the critical topic of ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐๐ฎ๐š๐ฅ๐ข๐ญ๐ฒ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ.

The session provided key insights into quality management principles, regulatory requirements, documentation practices, and compliance frameworks essential for maintaining high standards across pharmaceutical operations. Participants gained practical knowledge aligned with global regulatory expectations, strengthening their understanding of quality systems within the pharmaceutical industry.

A valuable learning experience for professionals committed to excellence in regulatory sciences and pharmaceutical research.

Dow Institute of Biological, Biochemical & Pharmaceutical Sciences (IBBPS-DUHS) delivers excellence in BA/BE studies thr...
14/01/2026

Dow Institute of Biological, Biochemical & Pharmaceutical Sciences (IBBPS-DUHS) delivers excellence in BA/BE studies through state-of-the-art facilities and adherence to global regulatory standards.

We partner with the pharmaceutical industry to advance innovation and patient safety.

Explore our solutions by visiting our website: https://lnkd.in/eKT2BARs

We proudly highlight another insightful session of the ๐๐ซ๐จ๐Ÿ๐ž๐ฌ๐ฌ๐ข๐จ๐ง๐š๐ฅ ๐ƒ๐ข๐ฉ๐ฅ๐จ๐ฆ๐š ๐ข๐ง ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐’๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ (๐๐š๐ญ๐œ๐ก...
10/01/2026

We proudly highlight another insightful session of the ๐๐ซ๐จ๐Ÿ๐ž๐ฌ๐ฌ๐ข๐จ๐ง๐š๐ฅ ๐ƒ๐ข๐ฉ๐ฅ๐จ๐ฆ๐š ๐ข๐ง ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐’๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ (๐๐š๐ญ๐œ๐ก ๐Ÿ), conducted by Dr. Sm.Zeeshan, focusing on the critical topic of ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐“๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ.

The session provided key insights into the clinical trial drug development process, regulatory pathways, ethical considerations, and compliance requirements essential for conducting successful clinical studies. Participants gained practical knowledge aligned with global regulatory expectations, strengthening their understanding of drug development within the pharmaceutical industry.

A valuable learning experience for professionals committed to excellence in regulatory sciences and pharmaceutical research.

๐‰๐จ๐ข๐ง ๐Ž๐ฎ๐ซ ๐”๐ฉ๐œ๐จ๐ฆ๐ข๐ง๐  ๐–๐ž๐›๐ข๐ง๐š๐ซ!โ€œ๐‚๐จ๐ฆ๐ฆ๐จ๐ง ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐ƒ๐ž๐Ÿ๐ข๐œ๐ข๐ž๐ง๐œ๐ข๐ž๐ฌ ๐ญ๐ก๐š๐ญ ๐ƒ๐ž๐ฅ๐š๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ ๐€๐ฉ๐ฉ๐ซ๐จ๐ฏ๐š๐ฅโ€๐Ÿ—“ Date: 14 January 2026โฐ Time: 11:...
06/01/2026

๐‰๐จ๐ข๐ง ๐Ž๐ฎ๐ซ ๐”๐ฉ๐œ๐จ๐ฆ๐ข๐ง๐  ๐–๐ž๐›๐ข๐ง๐š๐ซ!

โ€œ๐‚๐จ๐ฆ๐ฆ๐จ๐ง ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐ƒ๐ž๐Ÿ๐ข๐œ๐ข๐ž๐ง๐œ๐ข๐ž๐ฌ ๐ญ๐ก๐š๐ญ ๐ƒ๐ž๐ฅ๐š๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ ๐€๐ฉ๐ฉ๐ซ๐จ๐ฏ๐š๐ฅโ€

๐Ÿ—“ Date: 14 January 2026

โฐ Time: 11:00 โ€“ 12:00 PM

Regulatory deficiencies are one of the leading causes of delayed product approvals. This webinar will provide practical insights into the most common gaps identified by regulatory authorities and how organizations can proactively address them to ensure smoother and faster approvals.

๐–๐ก๐š๐ญ ๐˜๐จ๐ฎโ€™๐ฅ๐ฅ ๐‹๐ž๐š๐ซ๐ง:

โ€ข Common regulatory deficiencies observed during reviews

โ€ข Key documentation and compliance gaps that cause delays

โ€ข Regulatory expectations for successful submissions

โ€ข Strategies to minimize queries and deficiencies

โ€ข Best practices to accelerate product approval timelines

๐Ž๐ฎ๐ซ ๐’๐ฉ๐ž๐š๐ค๐ž๐ซ:

Dr. Jibran Khan, R. Ph., CRCP., PhD โ€“
Director Regulatory Affairs, Business Development & Pharmacovigilance
Adjunct Faculty | Jinnah University for Women

๐Œ๐จ๐๐ž๐ซ๐š๐ญ๐จ๐ซ:

Kanwal Mazhar Pirzada โ€“
Senior Clinical Research Associate
Dow Institute of Biological, Biochemical & Pharmaceutical Sciences (IBBPS-DUHS)

๐Ÿ‘‰ Register Now: https://forms.gle/XDg1HuchDrmVK4SFA

Be part of this insightful session and strengthen your regulatory knowledge for successful product approvals!

Embracing the New Year with renewed purpose, growth, and dedication. Wishing everyone a year filled with progress, succe...
31/12/2025

Embracing the New Year with renewed purpose, growth, and dedication. Wishing everyone a year filled with progress, success, and new opportunities. Happy New Year from the IBBPS family. โœจ"

We proudly highlight another insightful session of the ๐๐ซ๐จ๐Ÿ๐ž๐ฌ๐ฌ๐ข๐จ๐ง๐š๐ฅ ๐ƒ๐ข๐ฉ๐ฅ๐จ๐ฆ๐š ๐ข๐ง ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐’๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ (๐๐š๐ญ๐œ๐ก...
30/12/2025

We proudly highlight another insightful session of the ๐๐ซ๐จ๐Ÿ๐ž๐ฌ๐ฌ๐ข๐จ๐ง๐š๐ฅ ๐ƒ๐ข๐ฉ๐ฅ๐จ๐ฆ๐š ๐ข๐ง ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐’๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ (๐๐š๐ญ๐œ๐ก ๐Ÿ), conducted by ๐€๐ญ๐ข๐ช ๐ฎ๐ซ ๐‘๐ž๐ก๐ฆ๐š๐ง, focusing on the critical topic of ๐๐ก๐š๐ซ๐ฆ๐š ๐–๐š๐ญ๐ž๐ซ.

The session provided key insights into pharmaceutical water systems, regulatory requirements, quality standards, and compliance considerations essential for GMP environments. Participants gained practical knowledge aligned with global regulatory expectations, strengthening their understanding of quality systems within the pharmaceutical industry.

A valuable learning experience for professionals committed to excellence in regulatory sciences and pharmaceutical quality.

๐•๐จ๐ฅ๐ฎ๐ง๐ญ๐ž๐ž๐ซ ๐‘๐ž๐œ๐ซ๐ฎ๐ข๐ญ๐ฆ๐ž๐ง๐ญ ๐Ÿ๐จ๐ซ ๐๐ข๐จ๐ž๐ช๐ฎ๐ข๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž ๐’๐ญ๐ฎ๐๐ฒThe Institute of Biological, Biochemical & Pharmaceutical Sciences is recr...
30/12/2025

๐•๐จ๐ฅ๐ฎ๐ง๐ญ๐ž๐ž๐ซ ๐‘๐ž๐œ๐ซ๐ฎ๐ข๐ญ๐ฆ๐ž๐ง๐ญ ๐Ÿ๐จ๐ซ ๐๐ข๐จ๐ž๐ช๐ฎ๐ข๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž ๐’๐ญ๐ฎ๐๐ฒ

The Institute of Biological, Biochemical & Pharmaceutical Sciences is recruiting healthy volunteers for an upcoming Bioequivalence Study.

Screening Venue: Volunteer Healthcare Facility, DOW University Of Health Sciences - DUHS, Ojha Campus
Time: 09:00 AM - 1:00 PM
Eligibility Criteria:
- Healthy individuals aged 18-55 years
- Non-smokers
Benefits of Participation:
- Free comprehensive body checkup
- Supervised participation by qualified physicians and internationally trained pharmacists
For More Information:
Mobile: 0323-8633103 | 0301 1100527
Email: ibbps@duhs.edu.pk
Landline: 021-38771111 (Ext: 2914,2913)
Visit: Volunteer Healthcare Facility, Dow University of Health Sciences, Ojha Campus, Karachi

This study supports SDG 3: Good Health and Well-Being by promoting medical research, ensuring drug safety, and enhancing healthcare accessibility.

Volunteer Recruitment for Bioequivalence StudyThe Dow Institute of Biological, Biochemical & Pharmaceutical Sciences (IB...
23/12/2025

Volunteer Recruitment for Bioequivalence Study

The Dow Institute of Biological, Biochemical & Pharmaceutical Sciences (IBBPS, DUHS) is recruiting healthy volunteers for an upcoming Bioequivalence Study.

Screening Venue: Volunteer Healthcare Facility, Dow University of Health Sciences, Ojha Campus
Time: 09:00 AM - 1:00 PM

Eligibility Criteria:
- Healthy individuals aged 18-55 years
- Non-smokers

Benefits of Participation:
- Free comprehensive body checkup
- Supervised participation by qualified physicians and internationally trained pharmacists

For More Information:
Mobile: 0323-8633103 | 0301 1100527
Email: ibbps@duhs.edu.pk
Landline: 021-38771111 (Ext: 2914,2913)
Visit: Volunteer Healthcare Facility, Dow University of Health Sciences, Ojha Campus, Karachi

This study supports SDG 3: Good Health and Well-Being by promoting medical research, ensuring drug safety, and enhancing healthcare accessibility.

We proudly highlight another insightful session of the ๐๐ซ๐จ๐Ÿ๐ž๐ฌ๐ฌ๐ข๐จ๐ง๐š๐ฅ ๐ƒ๐ข๐ฉ๐ฅ๐จ๐ฆ๐š ๐ข๐ง ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐’๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ (๐๐š๐ญ๐œ๐ก...
20/12/2025

We proudly highlight another insightful session of the ๐๐ซ๐จ๐Ÿ๐ž๐ฌ๐ฌ๐ข๐จ๐ง๐š๐ฅ ๐ƒ๐ข๐ฉ๐ฅ๐จ๐ฆ๐š ๐ข๐ง ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐’๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ (๐๐š๐ญ๐œ๐ก ๐Ÿ) conducted by Sultan Ghani, focusing on the essential topic of ๐ˆ๐‚๐‡ ๐†๐ฎ๐ข๐๐ž๐ฅ๐ข๐ง๐ž ๐๐Ÿ–.

The session delivered comprehensive insights into Pharmaceutical Development as outlined in ICH Q8, emphasizing Quality by Design (QbD), critical quality attributes (CQAs), design space, and systematic approaches to product and process development.

Participants gained valuable understanding of science- and risk-based development strategies, lifecycle management, regulatory expectations, and best practices aligned with global quality standards โ€” making it a highly enriching learning experience for professionals dedicated to strengthening their expertise in pharmaceutical regulatory affairs and quality systems.

Address

Karachi

Telephone

+923472216545

Website

Alerts

Be the first to know and let us send you an email when Dow Institute of Biological Biochemical & Pharmaceutical Sciences-IBBPS posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Dow Institute of Biological Biochemical & Pharmaceutical Sciences-IBBPS:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category